Search research articles
Contact Us
Filters
Showing results (41-50 of 73) with videos related to
Page
of 8
Sort By:
Cancer Chemotherapy and Pharmacology
|
June 2, 2007
Evaluation of oral versus intravenous dose of vinorelbine to achieve equivalent blood exposures in patients with solid tumours
H Bourgeois, J Vermorken, G Dark, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
December 23, 1998
Ventricular arrhythmia and torsade de pointe: dose limiting toxicities of the MDR-modulator S9788 in a phase I trial
R Stupp, J Bauer, O Pagani, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
April 28, 2004
5-Fluorouracil as protracted continuous intravenous infusion can be added to full-dose docetaxel (Taxotere)-cisplatin in advanced gastric carcinoma: a phase I-II trial
A D Roth, R Maibach, N Fazio, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
April 9, 2005
Oxaliplatin combined with irinotecan and 5-fluorouracil/leucovorin (OCFL) in metastatic colorectal cancer: a phase I-II study
Y Seium, R Stupp, T Ruhstaller, et al.
Clinical Lymphoma
|
November 15, 2001
Weekly x 4 induction therapy with the anti-CD20 antibody rituximab: effect on circulating t(14;18)(+) follicular lymphoma cells
G Pichert, S F Schmitz, U Hess, et al.
European Journal of Cancer (Oxford, England : 1990)
|
November 29, 2011
Appropriate end-points for right results in the age of antiangiogenic agents: future options for phase II trials in patients with recurrent glioblastoma
A A Brandes, E Franceschi, T Gorlia, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
March 9, 2000
The effect of Rituximab on patients with follicular and mantle-cell lymphoma. Swiss Group for Clinical Cancer Research (SAKK)
M Ghielmini, S F Schmitz, K Bürki, et al.
European Journal of Nuclear Medicine and Molecular Imaging
|
February 4, 2005
The value of PET, CT and in-line PET/CT in patients with gastrointestinal stromal tumours: long-term outcome of treatment with imatinib mesylate
G W Goerres, R Stupp, G Barghouth, et al.
Nuklearmedizin. Nuclear Medicine
|
May 16, 2012
¹⁸F-fluorodeoxyglucose PET/CT findings in pleural effusions of patients with known cancer. A cytopathological correlation
I Letovanec, G Allenbach, A Mihaescu, et al.
Anti-Cancer Drugs
|
April 11, 2000
Phase II study of docetaxel alternating with cisplatin in chemotherapy-naïve patients with advanced non-small cell lung cancer
K Mattson, J Vansteenkiste, R Stupp, et al.
Page
of 8
Search research articles
Search
Showing results (41-50 of 73) with videos related to
Sort By:
Page
of 8
Cancer Chemotherapy and Pharmacology
|
June 2, 2007
Evaluation of oral versus intravenous dose of vinorelbine to achieve equivalent blood exposures in patients with solid tumours
H Bourgeois, J Vermorken, G Dark, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
December 23, 1998
Ventricular arrhythmia and torsade de pointe: dose limiting toxicities of the MDR-modulator S9788 in a phase I trial
R Stupp, J Bauer, O Pagani, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
April 28, 2004
5-Fluorouracil as protracted continuous intravenous infusion can be added to full-dose docetaxel (Taxotere)-cisplatin in advanced gastric carcinoma: a phase I-II trial
A D Roth, R Maibach, N Fazio, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
April 9, 2005
Oxaliplatin combined with irinotecan and 5-fluorouracil/leucovorin (OCFL) in metastatic colorectal cancer: a phase I-II study
Y Seium, R Stupp, T Ruhstaller, et al.
Clinical Lymphoma
|
November 15, 2001
Weekly x 4 induction therapy with the anti-CD20 antibody rituximab: effect on circulating t(14;18)(+) follicular lymphoma cells
G Pichert, S F Schmitz, U Hess, et al.
European Journal of Cancer (Oxford, England : 1990)
|
November 29, 2011
Appropriate end-points for right results in the age of antiangiogenic agents: future options for phase II trials in patients with recurrent glioblastoma
A A Brandes, E Franceschi, T Gorlia, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
March 9, 2000
The effect of Rituximab on patients with follicular and mantle-cell lymphoma. Swiss Group for Clinical Cancer Research (SAKK)
M Ghielmini, S F Schmitz, K Bürki, et al.
European Journal of Nuclear Medicine and Molecular Imaging
|
February 4, 2005
The value of PET, CT and in-line PET/CT in patients with gastrointestinal stromal tumours: long-term outcome of treatment with imatinib mesylate
G W Goerres, R Stupp, G Barghouth, et al.
Nuklearmedizin. Nuclear Medicine
|
May 16, 2012
¹⁸F-fluorodeoxyglucose PET/CT findings in pleural effusions of patients with known cancer. A cytopathological correlation
I Letovanec, G Allenbach, A Mihaescu, et al.
Anti-Cancer Drugs
|
April 11, 2000
Phase II study of docetaxel alternating with cisplatin in chemotherapy-naïve patients with advanced non-small cell lung cancer
K Mattson, J Vansteenkiste, R Stupp, et al.
Page
of 8